Lingyun Zheng

861 total citations
35 papers, 649 citations indexed

About

Lingyun Zheng is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Lingyun Zheng has authored 35 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Lingyun Zheng's work include Metabolomics and Mass Spectrometry Studies (7 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Lingyun Zheng is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (7 papers), Angiogenesis and VEGF in Cancer (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Lingyun Zheng collaborates with scholars based in China, United States and Australia. Lingyun Zheng's co-authors include Jiangchao Li, Cuiling Qi, Lijing Wang, Qianqian Zhang, Xiaofei Lv, Yong‐Bo Tang, Guan‐Lei Wang, Yongxia Yang, Yan‐Hua Du and Jia‐Guo Zhou and has published in prestigious journals such as Circulation, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lingyun Zheng

34 papers receiving 645 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyun Zheng China 15 379 110 83 71 71 35 649
Sijia Liang China 15 430 1.1× 180 1.6× 97 1.2× 67 0.9× 114 1.6× 32 754
Jingti Deng China 16 434 1.1× 157 1.4× 75 0.9× 98 1.4× 103 1.5× 31 767
Xiangxiang Wei China 11 497 1.3× 117 1.1× 70 0.8× 64 0.9× 79 1.1× 17 711
Barbara Kutryb-Zając Poland 15 277 0.7× 67 0.6× 77 0.9× 74 1.0× 78 1.1× 51 678
Ziwen Lu China 15 358 0.9× 182 1.7× 76 0.9× 67 0.9× 92 1.3× 50 661
Yongbo Zhao China 15 338 0.9× 179 1.6× 53 0.6× 32 0.5× 90 1.3× 30 635
Hsiang‐Ping Lee Taiwan 15 300 0.8× 101 0.9× 65 0.8× 35 0.5× 91 1.3× 16 682
Hiroyuki Kawagishi Japan 14 391 1.0× 121 1.1× 74 0.9× 48 0.7× 139 2.0× 23 893
Yimu Lai United States 15 427 1.1× 97 0.9× 113 1.4× 197 2.8× 80 1.1× 20 746
Yaqi Zhou China 15 294 0.8× 107 1.0× 72 0.9× 48 0.7× 116 1.6× 44 651

Countries citing papers authored by Lingyun Zheng

Since Specialization
Citations

This map shows the geographic impact of Lingyun Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Zheng more than expected).

Fields of papers citing papers by Lingyun Zheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyun Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Zheng. The network helps show where Lingyun Zheng may publish in the future.

Co-authorship network of co-authors of Lingyun Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Zheng. A scholar is included among the top collaborators of Lingyun Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Zheng. Lingyun Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Mai, Shunyi Wang, Wenjun Yang, et al.. (2024). ACVR1 mediates renal tubular EMT in kidney fibrosis via AKT activation. Cellular Signalling. 125. 111521–111521. 4 indexed citations
2.
Hu, Chenyang, Hao Wang, Lingyun Zheng, et al.. (2023). Exogenous melatonin orchestrates multiple defense responses against Botrytis cinerea in tomato leaves. Plant Stress. 11. 100326–100326. 6 indexed citations
3.
Liu, Qiao, Jian Chen, Yi Ding, et al.. (2023). CYD0281, a Bcl-2 BH4 domain antagonist, inhibits tumor angiogenesis and breast cancer tumor growth. BMC Cancer. 23(1). 6 indexed citations
4.
Li, Jinlian, Yuanyuan Li, Yongxia Yang, et al.. (2022). Decylubiquinone Inhibits Colorectal Cancer Growth Through Upregulating Sirtuin2. Frontiers in Pharmacology. 12. 804265–804265. 5 indexed citations
5.
Liu, Ying, Cuiling Qi, Lingyun Zheng, et al.. (2021). 1H-NMR based metabolic study of MMTV-PyMT mice along with pathological progress to screen biomarkers for the early diagnosis of breast cancer. Molecular Omics. 18(2). 167–177. 1 indexed citations
6.
Li, Junchen, Yi Ding, Yuying Yao, et al.. (2021). Andrographolide Suppresses the Growth and Metastasis of Luminal-Like Breast Cancer by Inhibiting the NF-κB/miR-21-5p/PDCD4 Signaling Pathway. Frontiers in Cell and Developmental Biology. 9. 643525–643525. 31 indexed citations
7.
Wang, Liping, Liping Wang, Jing Zheng, et al.. (2020). SLIT2 Overexpression in Periodontitis Intensifies Inflammation and Alveolar Bone Loss, Possibly via the Activation of MAPK Pathway. Frontiers in Cell and Developmental Biology. 8. 593–593. 26 indexed citations
8.
Hu, Xiwen, Jiangchao Li, Qianqian Zhang, et al.. (2020). Author Correction: Phosphoinositide 3-Kinase (PI3K) Subunit p110δ Is Essential for Trophoblast Cell Differentiation and Placental Development in Mouse. Scientific Reports. 10(1). 6906–6906. 1 indexed citations
9.
Zheng, Lingyun & Pengchao Sun. (2020). Increased Expression of IL-23 and IL-17 in Serum of Patients with Neonatal Respiratory Distress Syndrome and its Clinical Significance. Clinical Laboratory. 66(08/2020). 7 indexed citations
10.
Wang, Sheng, et al.. (2019). Gastric precancerous lesions present in ApcMin/+ mice. Biomedicine & Pharmacotherapy. 121. 109534–109534. 4 indexed citations
11.
Yao, Yuying, Zijun Zhou, Junchen Li, et al.. (2019). Activation of Slit2/Robo1 Signaling Promotes Tumor Metastasis in Colorectal Carcinoma through Activation of the TGF-β/Smads Pathway. Cells. 8(6). 635–635. 16 indexed citations
12.
Li, Qianming, Y. He, Xiaohua Liu, et al.. (2019). R5, a neutralizing antibody to Robo1, suppresses breast cancer growth and metastasis by inhibiting angiogenesis via down-regulating filamin A. Experimental Cell Research. 387(1). 111756–111756. 11 indexed citations
13.
14.
Qi, Cuiling, Bin Li, Yang Yang, et al.. (2016). Glipizide suppresses prostate cancer progression in the TRAMP model by inhibiting angiogenesis. Scientific Reports. 6(1). 27819–27819. 25 indexed citations
15.
Yang, Yongxia, et al.. (2015). Effects of high fructose and salt feeding on systematic metabonome probed via 1H NMR spectroscopy. Magnetic Resonance in Chemistry. 53(4). 295–303. 11 indexed citations
16.
Zheng, Lingyun, Teng Wu, Cuiling Zeng, et al.. (2015). SAP deficiency mitigated atherosclerotic lesions in ApoE−/− mice. Atherosclerosis. 244. 179–187. 21 indexed citations
17.
Lan, Tian, Changzheng Li, Lingyun Zheng, et al.. (2015). Activation of Slit2-Robo1 signaling promotes liver fibrosis. Journal of Hepatology. 63(6). 1413–1420. 75 indexed citations
18.
Yang, Yongxia, Linlin Wang, Shumei Wang, et al.. (2014). An integrated metabonomic approach to studying metabolic profiles in rat models with insulin resistance induced by high fructose. Molecular BioSystems. 10(7). 1803–1811. 17 indexed citations
19.
Yang, Yongxia, Ying Liu, Lingyun Zheng, et al.. (2014). Serum metabonomic analysis of apoE−/− mice reveals progression axes for atherosclerosis based on NMR spectroscopy. Molecular BioSystems. 10(12). 3170–3178. 17 indexed citations
20.
Zheng, Lingyun, Cuiling Zeng, Teng Wu, et al.. (2014). Inactivation of PI3Kδ Induces Vascular Injury and Promotes Aneurysm Development by Upregulating the AP-1/MMP-12 Pathway in Macrophages. Arteriosclerosis Thrombosis and Vascular Biology. 35(2). 368–377. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026